Results
eNauka >
Rezultati >
Cilengitide combined with standard treatment for patients with newly diagnosed glioblastoma with methylated MGMT promoter (CENTRIC EORTC 26071-22072 study): a multicentre, randomised, open-label, phase 3 trial
| Naziv: | Cilengitide combined with standard treatment for patients with newly diagnosed glioblastoma with methylated MGMT promoter (CENTRIC EORTC 26071-22072 study): a multicentre, randomised, open-label, phase 3 trial | Autori  : | Stupp, Roger; ...; Grujicic, Danica M; ...; (broj, koautora 37) | Godina: | 2014 | Publikacija: | LANCET ONCOLOGY | ISSN: | 1470-2045 Lancet Oncology Pretraži identifikator |
Tip rezultata: | Naučni članak | Kolacija: | vol. 15 br. 10 str. 1100-1108 | DOI: | 10.1016/S1470-2045(14)70379-1 | WoS-ID: | 000341312500051 | Scopus-ID: | 2-s2.0-84908563697 | URI: | https://enauka.gov.rs/handle/123456789/812245 | Projekat: | Merck KGaA, Darmstadt, Germany | Izvor metapodataka: | (Preuzeto iz Nasi u WoS) | M-kategorija: | 21a+M21a+ - Vodeći međunarodni časopis kategorije M21a+ |
Items in eNauka are protected by copyright, with all rights reserved, unless otherwise indicated.